CF vs PRLD · P/E 12, rev $5.94B vs rev $6.5M
CF Industries Holdings Inc (CF) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
CF currently screens at market cap $14.98B and trailing P/E 12.2. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the CF and PRLD stock pages for the full models.
Not investment advice.